Business
Extension of a 5 year contract
Extension of a 5 year contract.
About this update from Ixico Plc
[{"type":"text","content":"\n \nRNS Number : 7886P IXICO plc 05 September 2017 \n\n5 September 2017\n \nIXICO plc\n \n(\"IXICO\" or the \"Company\")\n \nExtension of a 5 year contract in a Phase II/III Alzheimer's Disease clinical trial \nwith a top 10 global pharmaceutical company\n \nIXICO plc (AIM: IXI), the digital technologies company serving neuroscience, today announces that it has signed an extension and expansion to its largest existing contract, which was awarded in August 2015, for a Phase II/III clinical trial contract in Alzheimer's Disease. Consequently, the total contract value has increased from US$6.8m to US$7.7m, of which US$1.0m has been recognised to date. The contract term has been extended by eight months to May 2024.\n \nIn this study IXICO utilises its expertise and proprietary technology platform to collect, measure and monitor changes in disease pathology of participants in the trial. The expansion reflects the addition of additional image data standardisation and collection services, which will be provided over the duration of the study.\n \nGiulio Cerroni, CEO of IXICO, commented\n \n\"We are delighted to announce an extension to this significant existing agreement which reflects the opportunities we continue to develop to enhance our privileged position as trusted partners, to provide additional technology enabled services to our pharmaceutical customers\".\n \nFor further information please contact: \n \n\n\n\n\nIXICO plc \nGiulio Cerroni, Chief Executive Officer\nSusan Lowther, Chief Financial Officer\n\n\nTel: +44 20 3763 7499\n\n\n\n\n\n\n\n\n\n\n\n\nShore Capital (Nomad and Broker)\nBidhi Bhoma / Edward Mansfield /James Wolfe\n\n\nTel: +44 20 7408 4090\n\n\n\n\n\n\n\n\n\n\n\n\nFTI Consulting Limited (Investor Relations)\nSimon Conway / Mo Noonan\n\n\nTel: +44 20 3727 1000\n\n\n\n\n \nAbout IXICO\n \nIXICO is the digital technologies company serving neuroscience. Our mission is to transform the pursuit of improving brain health through the application of digital technologies to neuroscience. IXICO's specialist data analytics services are used by the global pharmaceutical industry to select participants for clinical trials, assess the safety and efficacy of new drugs in development and in post marketing surveillance. Our neurological disease focus incl...